IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis

Status Terminated

Clinical Trial Summary

Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic technique utilized to diagnose and treat pathologic conditions involving the ducts draining the liver and pancreas. Post-ERCP pancreatitis (PEP) is the most common complication following ERCP and occurs in approximately 11% of children undergoing the procedure. By definition it leads to prolongation of hospital stay or delays in care and rarely can result in long-term morbidity or even death. Recent adult trials have demonstrated prevention of PEP with administration of rectal nonsteroidal anti-inflammatory drugs (NSAIDS). To date, no studies have been performed in children thus no "gold standard" or even commonly accepted method of preventing PEP in the pediatric population exist. Studying an IV NSAID such as ibuprofen has distinct advantages over rectally administered NSAIDs in the pediatric population in that it would allow for more consistent weight based dosing and would have more predictable absorption compared to suppository. Thus, this project proposes a pilot study evaluating the effectiveness of IV ibuprofen at preventing PEP in the pediatric population. The design of the proposed study is a prospective randomized double-blind trial comparing IV Ibuprofen to placebo controls (normal saline) at the time of procedure in patients undergoing ERCP at Children's Medical Center Dallas over a two-year period. The primary outcome measurement will be development of PEP. Post-ERCP bleeding and change in pre- and post- procedural pain scores will also be measured. The hypothesis is that IV Ibuprofen administered at the time of ERCP will decrease rates of post-ERCP pancreatitis in pediatric patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02241512
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact
Status	Terminated
Phase	Phase 2
Start date	September 2014
Completion date	September 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546867` - Establishing a Sonographic Based Algorithm to Verify Pancreatic Stent Position Placed to Prevent Post-ERCP Pancreatitis Before Endoscopic Removal	N/A
Completed	`NCT00222092` - Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers	Phase 4
Completed	`NCT05310409` - PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
Not yet recruiting	`NCT06260878` - Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis	Phase 4
Not yet recruiting	`NCT04770857` - Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
Completed	`NCT02641561` - Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis	Phase 3
Active, not recruiting	`NCT04145336` - 7 cm vs. 5 cm Pancreatic Stents for the Prevention of Post-ERCP Pancreatitis in High-risk Patients	N/A
Completed	`NCT03629600` - Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis	Phase 2/Phase 3
Recruiting	`NCT03756116` - Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide	N/A
Recruiting	`NCT05664074` - Rectal Indomethacin vs Intravenous Ketorolac	Phase 4
Completed	`NCT02308891` - A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis	N/A
Recruiting	`NCT05336630` - Study of Forceps Cannulation During ERCP	N/A
Recruiting	`NCT05857514` - Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis	N/A
Recruiting	`NCT05267379` - An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
Recruiting	`NCT05947461` - Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac	N/A
Completed	`NCT03098082` - Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis	N/A
Recruiting	`NCT02830984` - ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP	N/A
Recruiting	`NCT02839356` - Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis	Phase 4
Completed	`NCT01673763` - Post-ERCP Pancreatitis Prevention by Stent Insertion	N/A
Active, not recruiting	`NCT04425993` - Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention	N/A